Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (141-150 of 194) with videos related to

Pageof 20
Sort By:
Journal of Computer Assisted Tomography|September 20, 2011
Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patientsHironao Hozumi, Yutaro Nakamura, Takeshi Johkoh, et al.
BMC Cancer|March 24, 2022
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysisSenri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, et al.
BMC Cancer|July 20, 2021
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trialsSenri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sitesKatsuhiro Yoshimura, Yusuke Inoue, Masato Karayama, et al.
ERJ Open Research|May 25, 2023
Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosisYuzo Suzuki, Atsuki Fukada, Kazutaka Mori, et al.
BMC Cancer|October 2, 2025
Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trialsSuguru Kojima, Naoki Inui, Takahito Suzuki, et al.
BMC Pulmonary Medicine|May 8, 2022
Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epitheliumMineo Katsumata, Tomoyuki Fujisawa, Yosuke Kamiya, et al.
Respiratory Research|November 11, 2021
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumoniasTomoyuki Fujisawa, Yasuoki Horiike, Ryoko Egashira, et al.
BMC Pulmonary Medicine|October 27, 2022
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseasesNoriyuki Enomoto, Hyogo Naoi, Yasutaka Mochizuka, et al.
Respiratory Medicine|November 12, 2019
Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseasesYosuke Kamiya, Tomoyuki Fujisawa, Masato Kono, et al.
Pageof 20

Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
Journal of Computer Assisted Tomography|September 20, 2011
Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patientsHironao Hozumi, Yutaro Nakamura, Takeshi Johkoh, et al.
BMC Cancer|March 24, 2022
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysisSenri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, et al.
BMC Cancer|July 20, 2021
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trialsSenri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sitesKatsuhiro Yoshimura, Yusuke Inoue, Masato Karayama, et al.
ERJ Open Research|May 25, 2023
Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosisYuzo Suzuki, Atsuki Fukada, Kazutaka Mori, et al.
BMC Cancer|October 2, 2025
Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trialsSuguru Kojima, Naoki Inui, Takahito Suzuki, et al.
BMC Pulmonary Medicine|May 8, 2022
Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epitheliumMineo Katsumata, Tomoyuki Fujisawa, Yosuke Kamiya, et al.
Respiratory Research|November 11, 2021
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumoniasTomoyuki Fujisawa, Yasuoki Horiike, Ryoko Egashira, et al.
BMC Pulmonary Medicine|October 27, 2022
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseasesNoriyuki Enomoto, Hyogo Naoi, Yasutaka Mochizuka, et al.
Respiratory Medicine|November 12, 2019
Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseasesYosuke Kamiya, Tomoyuki Fujisawa, Masato Kono, et al.
Pageof 20